Cargando…
Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal disease which has a major impact on patients’ quality of life (QOL). Except for lung transplantation, there is no curative treatment option. Fortunately, two disease-modifying drugs that slow down disease decline were recently...
Autores principales: | Moor, Catharina C., Heukels, Peter, Kool, Mirjam, Wijsenbeek, Marlies S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742327/ https://www.ncbi.nlm.nih.gov/pubmed/29326935 http://dx.doi.org/10.3389/fmed.2017.00226 |
Ejemplares similares
-
The use of online visual analogue scales in idiopathic pulmonary fibrosis
por: Moor, Catharina C., et al.
Publicado: (2022) -
Aberrant B Cell Receptor Signaling in Naïve B Cells from Patients with Idiopathic Pulmonary Fibrosis
por: Neys, Stefan F. H., et al.
Publicado: (2021) -
Cough in idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2016) -
Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension
por: Heukels, Peter, et al.
Publicado: (2021) -
Enhanced Bruton’s tyrosine kinase in B-cells and autoreactive IgA in patients with idiopathic pulmonary fibrosis
por: Heukels, Peter, et al.
Publicado: (2019)